In addition, patients of both MARK4 groups frequently displayed several cardiovascular risk factors including obesity (body mass index [BMI]: 28.6 ± 4.5 kg/m2), diabetes mellitus, hyperlipidemia, and arterial hypertension. This evidence concerns the gene MARK4 and obesity due to melanocortin 4 receptor deficiency.